Financial intelligence for Asia's healthcare markets
Remember me:

Singapore: Novena makes acquisitions in Singapore and Taiwan

Singapore-based Novena Global Lifecare Group, one of Asia’s largest and fastest-growing integrated medical healthcare and aesthetic groups, has announced a number of acquisitions. It has bought four eye care centres in Singapore and a majority stake in Taiwan’s Hexin Group, the third largest healthcare screening provider in Taipei. Financial terms have not been disclosed.

In Singapore it has acquired Total EyeCare Center at Orchid Hotel and a branch in Jurong East with a client base of more than 25,000 patients; and the Specialist Eye & Eyelids Clinic at Novena and The Eye & Aesthetics Clinic in Suntec City.

“This investment is the first of several to come as we execute our vision to provide integrated and quality healthcare and medical aesthetic services at affordable prices to our patients in Singapore and the region,” said Nelson Loh, executive chairman and co-founder of Novena Global.

The acquisition of a majority stake in Hexin will allow Novena Global to manage and oversee healthcare screening services in some of the largest hospitals in Taipei, namely Taipei Medical University Hospital, Taoyuan General Hospital, China Medical University Hospital and Taipei Beitou Hospital.

Hexin Group was founded in 2007 and works with hospitals in Taiwan to provide health monitoring services to corporate clients’ employees. Its key corporate accounts include the top MNC companies in financial services, electronics, biotech, hospitality, consumer and retail sectors. In all, Hexin provides health screening for over 200,000 corporate employees.

In Taiwan, Novena Global said that it also plans to develop predictive care through DNA testing with its partnership with another Taiwanese company, Health GeneTech. It will work with leading universities and regional labs in Taiwan, Korea, India and Hong Kong to develop an extensive database on Asian genetics for predictive developmental and healthcare management.

It is also in talks with what it calls “a Taiwan leading healthcare group” to develop a maternity care centre as it sees a growing market for post-natal care in Singapore.

In late July Novena Global announced that it plans to raise US$150 million through a listing on the Taiwan Stock Exchange to expand regionally in North Asia both organically and through acquisitions.

Posted on: 16/11/2017 UTC+08:00


Global private equity firms, including KKR, CVC and Carlye, are reported to be be bidding for Columbia Pacific Management’s Asian hospital business, Columbia Asia Group.
Hong Kong-based Baring Private Equity Asia is set to acquire AGS Health, a medical revenue cycle management company for $320 million.
Triple Ten, a multi-national holding company based in Hong Kong, has invested in C-BeyondHealth, a US product development company specialising in medicinal cannabinoid products.
Everlife, private equity firm Everstone Capital’s pan-Asian healthcare platform, has invested in in-vitro diagnostics (IVD) products manufacturer CPC Diagnostics, enabling the company to take its product portfolio to new markets and customers.
The Hong Kong government is to set up a public healthcare stabilisation fund using a $10 billion cut of the 2019 budget to further support the public healthcare sector, finance secretary Paul Chan Mo-po has announced.
India’s Life Insurance Council is to ask the Insurance Regulatory and Development Authority of India to reinstate its right to sell indemnity health cover, which allows policyholders to reclaim money after visiting a doctor.
Major international and local insurance companies are joining Hong Kong’s big new private medical coverage initiative, introduced to relieve pressure from the territory’s overburden public health system.
Aged care provider and health insurer Bupa has paid the Australian tax office A$157 million after settling a long-running dispute.


Sumit Sharma and Matt Zafra, head and principal of health & life sciences, Asia Pacific at Oliver Wyman, look at what we can expect in 2019.
Edwin Tong, senior minister for health, explains how the Ministry of Health in Singapore is supporting the growth in the number of seniors with Alzheimer's.
Penny Wan, regional vice-president and general manager, Japan and APAC, Amgen, writes about the public health challenge of cardiovascular diseases.
French-based international ophthalmic optics company Essilor has signed Letters of Intent with the Royal Government of Bhutan and the Central Monastic Body to strengthen the country’s vision care infrastructure.
April Chang, country manager at Cigna Singapore, argues that wellness programmes at work can lead to reduced absenteeism, higher productivity and increased morale among employees.
Steven Fang understands how to set up a healthcare company. Not only is he chief executive and founder of ASX-listed oncology company Invitrocue, he was also the founder of Singapore-based Cordlife Group, a healthcare company which provides cord blood and cord lining banking services.
Imagine a world in which you can consult with your doctor via video. She asks for a blood sample, which can be collected and analysed from a device in your home. After that is diagnosed, the prescription is automatically sent to the pharmacy and Uber then picks it up. The time from diagnosis to drugs at your home is only 60 minutes.
The digitisation of health data through blockchain technology is a groundbreaking solution that will empower patients and provide them with better access to healthcare.
my images


HealthInvestor Asia twitter feed